Clinical Trials Browser

Phase 2 × INDUSTRY × Advanced Non-small Cell Lung Cancer (NSCLC) × Clear all

NCT02175017 2024-12-09

ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

104 enrolled 21 charts

Advanced Non-small Cell Lung Cancer (NSCLC)

NCT01101334 2020-06-16

Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer

Phase 2 Completed

90 enrolled 11 charts

Advanced Non-small Cell Lung Cancer (NSCLC)